BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 20816168)

  • 1. Targeted genetic inactivation of N-acetylglucosaminyltransferase-IVa impairs insulin secretion from pancreatic beta cells and evokes type 2 diabetes.
    Ohtsubo K
    Methods Enzymol; 2010; 479():205-22. PubMed ID: 20816168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physiological and glycomic characterization of N-acetylglucosaminyltransferase-IVa and -IVb double deficient mice.
    Takamatsu S; Antonopoulos A; Ohtsubo K; Ditto D; Chiba Y; Le DT; Morris HR; Haslam SM; Dell A; Marth JD; Taniguchi N
    Glycobiology; 2010 Jan; 20(4):485-97. PubMed ID: 20015870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of a lectin domain that regulates enzyme activity in mouse N-acetylglucosaminyltransferase-IVa (MGAT4A).
    Nagae M; Hirata T; Tateno H; Mishra SK; Manabe N; Osada N; Tokoro Y; Yamaguchi Y; Doerksen RJ; Shimizu T; Kizuka Y
    Commun Biol; 2022 Jul; 5(1):695. PubMed ID: 35854001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HCV affects K
    Niu B; Ma L; Yao L; Zhang Y; Su H
    Endocrine; 2024 May; 84(2):427-440. PubMed ID: 37962815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetic properties and substrate specificities of two recombinant human N-acetylglucosaminyltransferase-IV isozymes.
    Oguri S; Yoshida A; Minowa MT; Takeuchi M
    Glycoconj J; 2006 Nov; 23(7-8):473-80. PubMed ID: 17006639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-glycosylation by N-acetylglucosaminyltransferase IVa enhances the interaction of integrin β1 with vimentin and promotes hepatocellular carcinoma cell motility.
    Yang D; Han F; Cai J; Sun H; Wang F; Jiang M; Zhang M; Yuan M; Zhou W; Li H; Yang L; Bai Y; Xiao L; Dong H; Cheng Q; Mao H; Zhou L; Wang R; Li Y; Nie H
    Biochim Biophys Acta Mol Cell Res; 2023 Oct; 1870(7):119513. PubMed ID: 37295747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-acetylglucosaminyltransferase IVa promotes invasion of choriocarcinoma.
    Nishino K; Yamamoto E; Niimi K; Sekiya Y; Yamashita Y; Kikkawa F
    Oncol Rep; 2017 Jul; 38(1):440-448. PubMed ID: 28534963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-acetylglucosaminyltransferase IVa regulates metastatic potential of mouse hepatocarcinoma cells through glycosylation of CD147.
    Fan J; Wang S; Yu S; He J; Zheng W; Zhang J
    Glycoconj J; 2012 Aug; 29(5-6):323-34. PubMed ID: 22736280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-Glycosylation modulates the membrane sub-domain distribution and activity of glucose transporter 2 in pancreatic beta cells.
    Ohtsubo K; Takamatsu S; Gao C; Korekane H; Kurosawa TM; Taniguchi N
    Biochem Biophys Res Commun; 2013 May; 434(2):346-51. PubMed ID: 23548572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dietary and genetic control of glucose transporter 2 glycosylation promotes insulin secretion in suppressing diabetes.
    Ohtsubo K; Takamatsu S; Minowa MT; Yoshida A; Takeuchi M; Marth JD
    Cell; 2005 Dec; 123(7):1307-21. PubMed ID: 16377570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular cloning and characterization of human GnT-IX, a novel beta1,6-N-acetylglucosaminyltransferase that is specifically expressed in the brain.
    Inamori K; Endo T; Ide Y; Fujii S; Gu J; Honke K; Taniguchi N
    J Biol Chem; 2003 Oct; 278(44):43102-9. PubMed ID: 12941944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Examination of differential glycoprotein preferences of N-acetylglucosaminyltransferase-IV isozymes a and b.
    Osada N; Nagae M; Nakano M; Hirata T; Kizuka Y
    J Biol Chem; 2022 Sep; 298(9):102400. PubMed ID: 35988645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of N-glycan units for assessment of substrate structural requirements of N-acetylglucosaminyltransferase III.
    Hanashima S; Korekane H; Taniguchi N; Yamaguchi Y
    Bioorg Med Chem Lett; 2014 Sep; 24(18):4533-4537. PubMed ID: 25139566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of paucimannose N-glycans by Caenorhabditis elegans requires prior actions of UDP-N-acetyl-D-glucosamine:alpha-3-D-mannoside beta1,2-N-acetylglucosaminyltransferase I, alpha3,6-mannosidase II and a specific membrane-bound beta-N-acetylglucosaminidase.
    Zhang W; Cao P; Chen S; Spence AM; Zhu S; Staudacher E; Schachter H
    Biochem J; 2003 May; 372(Pt 1):53-64. PubMed ID: 12603202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific N-glycans of Hepatocellular Carcinoma Cell Surface and the Abnormal Increase of Core-α-1, 6-fucosylated Triantennary Glycan via N-acetylglucosaminyltransferases-IVa Regulation.
    Nie H; Liu X; Zhang Y; Li T; Zhan C; Huo W; He A; Yao Y; Jin Y; Qu Y; Sun XL; Li Y
    Sci Rep; 2015 Nov; 5():16007. PubMed ID: 26537865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrant expression of N-acetylglucosaminyltransferase-IVa and IVb (GnT-IVa and b) in pancreatic cancer.
    Ide Y; Miyoshi E; Nakagawa T; Gu J; Tanemura M; Nishida T; Ito T; Yamamoto H; Kozutsumi Y; Taniguchi N
    Biochem Biophys Res Commun; 2006 Mar; 341(2):478-82. PubMed ID: 16434023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulation of N-acetylglucosaminyltransferase-V by heparin-binding EGF-like growth factor induces keratinocyte proliferation and epidermal hyperplasia.
    Kimura A; Terao M; Kato A; Hanafusa T; Murota H; Katayama I; Miyoshi E
    Exp Dermatol; 2012 Jul; 21(7):515-9. PubMed ID: 22716246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of expression of N-acetylglucosaminyltransferase Va results in altered gene expression of glycosyltransferases and galectins.
    Guo HB; Nairn A; Harris K; Randolph M; Alvarez-Manilla G; Moremen K; Pierce M
    FEBS Lett; 2008 Feb; 582(4):527-35. PubMed ID: 18230362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Core O-glycans required for lymphocyte homing gene knockout mice of core 1 beta1,3-N-acetylglucosaminyltransferase and core 2 N-acetylglucosaminyltransferase.
    Mitoma J; Fukuda M
    Methods Enzymol; 2010; 479():257-70. PubMed ID: 20816171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperexpression of N-acetylglucosaminyltransferase-III in liver tissues of transgenic mice causes fatty body and obesity through severe accumulation of Apo A-I and Apo B.
    Lee J; Song EY; Chung TW; Kang SK; Kim KS; Chung TH; Yeom YI; Kim CH
    Arch Biochem Biophys; 2004 Jun; 426(1):18-31. PubMed ID: 15130779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.